Bain-Backed Emcure Pharmaceuticals Eyes $672 Mln IPO � Source

[email protected]07 Sep, 2021News

BENGALURU, Aug 19 (Reuters) ? India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter said could be worth up to 50 billion rupees ($671.89 million). Emcure is the latest Indian company to tap capital markets this year in a fund-raising frenzy driven by abundant liquidity and record-high stock markets.

Recent Profiles

TopPropOffers

Toppropoffers

View Profile

keobongdagous

Keobongdagous

View Profile

Socialventure capitalist

Socialventure Capitalist

View Profile

Skylake Medical Associates

Skylake Medical Associates

View Profile

ceoshbet2026

Ceoshbet2026

View Profile

Suppleverse

Suppleverse

View Profile

ディルド

ディルド

View Profile

Infinia Yachts

Infinia Yachts

View Profile

7J777

7j777

View Profile